The Latest Cardiac and Vascular News
Certification recognizes full-team approach to cardiac care DANVILLE, Pa., Aug. 17, 2022 /PRNewswire/ — Geisinger Medical Center (GMC) is the country’s first hospital to receive The Joint Commission/American Heart Association (AHA) Comprehensive Heart Attack Center Certification. Already recognized by the organizations as a Mission Lifeline® Heart Attack Receiving Center for its ability to […]
PRINCETON, N.J., Aug. 17, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced that the Israeli Ministry of Health (MoH) has approved national reimbursement for CytoSorb® in certain cardiac surgery indications that […]
Consistent evidence supports benefits of complete revascularization on LVEF, heart failure symptoms DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (Nasdaq: ABMD) announces the results of the Restore EF study demonstrate Impella-supported high-risk percutaneous coronary intervention (PCI) leads to significant improvements in left ventricular ejection fraction (LVEF), angina symptoms and heart failure symptoms at follow-up. The study, […]
HOUSTON, Aug. 16, 2022 /PRNewswire/ — Millar, Inc., a medical device manufacturer and OEM solutions partner, is pleased to announce that they have received approval from the Therapeutic Goods Administration (TGA) in Australia for their Mikro-Cath™ Pressure Catheter. The Mikro-Cath™ is a single–use pressure catheter intended to be used for medical research and diagnostic purposes. The […]
To provide a full spectrum of innovative solutions, the partnership aims to empower better heart care and build efficiency across the care pathway journey of the patient Unlocking the potential of interventional cardiology will be a step forward in delivering precision health BENGALURU, India, Aug. 16, 2022 /PRNewswire/ — GE Healthcare, a leading global […]
• Topline data expected mid-2023 • EXPLORER-CN trial, together with PK study conducted in healthy Chinese volunteers, expected to support registration of mavacamten in China SHANGHAI, China and PRINCETON, N.J., Aug. 10, 2022 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in […]
Oxford University mathematics program paired students & faculty with Vironix technologists to develop and validate algorithms for synthetic patient data generation and detection of Congestive Heart Failure decompensation. AUSTIN, Texas, Aug. 9, 2022 /PRNewswire/ — Digital Health Company, Vironix Health, has teamed up with the Mathematical Modelling and Scientific Computing MSc, based within […]
The Bodyport Cardiac Scale is available to monitor heart function and fluid status in a single step at home SAN FRANCISCO–(BUSINESS WIRE)–Bodyport, a digital therapeutics company on a mission to address complex chronic conditions, announced today that its noninvasive biomarker platform, the Bodyport Cardiac Scale™ received U.S. Food & Drug […]
Modern Heart and Vascular Institute is proud to offer an intensive cardiac rehabilitation program designed to help patients get back to their normal lives after being diagnosed with cardiovascular disease. HUMBLE, Texas, Aug. 08, 2022 (GLOBE NEWSWIRE) — Modern Heart and Vascular is now offering intensive cardiac rehabilitation for patients […]
Successfully met the primary endpoint in the BrigHtn trial, delivering a 20.3 mmHg reduction in systolic blood pressure (SBP), or an 11 mmHg (p-value < 0.0001) decline on a placebo-adjusted basis, at 2 mg dose Independent Data Review Committee determined that the trial met pre-specified statistical criteria of overwhelming efficacy […]
